Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial.
Saved in:
| Title: | Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial. |
|---|---|
| Authors: | Haag, Georg Martin1,2 (AUTHOR) GeorgMartin.Haag@med.uni-heidelberg.de, Springfeld, Christoph1 (AUTHOR), Grün, Barbara1 (AUTHOR), Apostolidis, Leonidas1 (AUTHOR), Zschäbitz, Stefanie1 (AUTHOR), Dietrich, Mareike1 (AUTHOR), Berger, Anne-Katrin1 (AUTHOR), Weber, Tim Frederik3 (AUTHOR), Zoernig, Inka1 (AUTHOR), Schaaf, Marina4 (AUTHOR), Waberer, Lisa4 (AUTHOR), Müller, Daniel Wilhelm5 (AUTHOR), Al-Batran, Salah-Eddin5 (AUTHOR), Halama, Niels1,6 (AUTHOR), Jaeger, Dirk1,2 (AUTHOR) |
| Source: | European Journal of Cancer. May2022, Vol. 167, p112-122. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2022.03.017 |
